With the changing population structure, the evolving spectrum of chronic diseases, and continuous advancements in medical technology, the global healthcare model is undergoing a significant transformation—from disease treatment to precision diagnosis and therapy, and from invasive procedures to minimally invasive approaches. As an important direction in the development of modern medicine, interventional therapy, with its advantages of minimal trauma, high precision, and short recovery periods, is becoming a key technical pathway for the treatment of cardiovascular, peripheral vascular, and other related diseases.As an innovative enterprise focused on the research, development, and manufacturing of vascular interventional medical devices, Coury Medical consistently centers on clinical needs and industry development trends. The company continues to build a full-chain capability system spanning technology R&D, product innovation, and large-scale manufacturing. It is committed to accelerating the translation of high-performance interventional medical device R&D achievements into practical applications, providing clinicians with safer, more efficient, and more precise solutions.
Coury Medical Production & Manufacturing Base
Deeply Engaged in Intervention, Building a Clinically Driven Innovation System
Focusing on the vascular interventional field, Coury Medical develops its product portfolio around the entire clinical treatment process. The company continuously advances multi-directional technology R&D covering access establishment, interventional therapy, and adjunctive applications, thereby building a product system that serves multiple clinical scenarios. Guided by clinical value, Coury Medical integrates physicians’ practical needs throughout the entire product development process. Through structural design optimization, material performance enhancement, and manufacturing process innovation, the company continuously improves product performance and application adaptability. At the same time, Coury Medical closely tracks the technological development trends in interventional therapy, actively explores additional clinical application scenarios, and drives the ongoing upgrade of its products toward higher performance and greater reliability.
Coury Product: Micro Introducer Sheath
Coury Product: PTA Balloon Catheter
Building Competitive Barriers in the Industrialization of High-End Interventional Devices Through End-to-End Manufacturing Strength
For interventional medical devices, every stage—from material selection and structural design to precision machining, assembly, and verification—has a critical impact on product performance and quality stability. Complete in-house manufacturing capability has become a core competitive advantage for the sustainable development of enterprises.
Coury Medical insists on independently controlling its core manufacturing processes and continuously builds a full-process industrialization system covering R&D, production, and testing. It is one of the few domestic enterprises that possess full-process autonomous manufacturing capabilities for interventional medical devices. Focusing on the needs of product R&D and large-scale production, the company continuously improves its complete manufacturing chain—from raw material processing, precision forming, and micro-machining to product assembly and verification. All core production stages are completed in-house, thereby enhancing product development efficiency, process consistency, and quality controllability.
Full-Process Industrialization System
Meanwhile, the company continuously promotes the upgrade of its manufacturing system toward automation and intelligence. It introduces automated production equipment, strengthens process control over critical procedures, and enhances production efficiency and product consistency through lean manufacturing, thereby driving the transformation of medical device production from traditional experience-based manufacturing to data-driven precision manufacturing.
Committed to Long-Term Technology Accumulation for Continuous Innovation Capability
The medical device industry is characterized by a long cycle of technological accumulation, substantial R&D investment, and high requirements for industrial collaboration. Truly competitive enterprises need not only to launch products but also to establish the capability to continuously generate innovative outcomes.
Looking ahead, Coury Medical will continue to promote the deep integration of R&D innovation and intelligent manufacturing, drive more innovative achievements to serve clinical needs, and contribute to the high-quality development of China’s high-end medical device industry.